The Group has entered into research collaborations with both academia and research organisations, including:

• Imperial College London (UK), a pioneer and world-leading university in the biomarker field, to identify biomarkers of AIT efficacy and expand knowledge regarding the pathophysiology of allergic diseases and their treatment with AIT.
• Alyatec a contract research organisation based in Strasbourg University Hospital (France), to advance precision medicine in AIT. With this collaboration, Stallergenes Greer aimes to strenghten its precision medicine-based approach and the management of patients with allergies by expanding its knowledge of allergy pathophysiology and endotypes, AIT mode of action and clinical validation.
• Swiss Institute of Allergy and Asthma Research (SIAF), a world-class institution focusing on basic research in the field of allergies and asthma to identify predictive signature patterns for patient stratification.